Differences Between Anticoagulated Patients With Ischemic Stroke Versus Intracerebral Hemorrhage
Conclusions In patients presenting with stroke on oral anticoagulant, AIS/TIA was 5 times more common than ICH. A high atherosclerotic burden (indicated by cardiovascular comorbidities and extracranial atherosclerosis) and prior AIS/TIA contributed more to AIS/TIA, while small vessel disease markers and prior ICH were stronger determinants for ICH. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT02353585.PMID:34935409 | DOI:10.1161/JAHA.121.023345
Source: Atherosclerosis - Category: Cardiology Authors: Fabian Schaub Alexandros A Polymeris Sabine Schaedelin Lisa Hert Louisa Meya Sebastian Thilemann Christopher Traenka Benjamin Wagner David Seiffge Henrik Gensicke Gian Marco De Marchis Leo Bonati Stefan T Engelter Nils Peters Philippe Lyrer Source Type: research
More News: Brain | Cardiology | Cardiovascular | Cholesterol | Heart | Hemorrhagic Stroke | Ischemic Stroke | Neurology | Statin Therapy | Stroke | Study | Vitamin K | Vitamins